Cargando…
Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135300/ https://www.ncbi.nlm.nih.gov/pubmed/37124500 http://dx.doi.org/10.3389/fonc.2023.1163510 |
| _version_ | 1785031944621260800 |
|---|---|
| author | Donovan, Johnny Deng, Zicheng Bian, Fenghua Shukla, Samriddhi Gomez-Arroyo, Jose Shi, Donglu Kalinichenko, Vladimir V. Kalin, Tanya V. |
| author_facet | Donovan, Johnny Deng, Zicheng Bian, Fenghua Shukla, Samriddhi Gomez-Arroyo, Jose Shi, Donglu Kalinichenko, Vladimir V. Kalin, Tanya V. |
| author_sort | Donovan, Johnny |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10135300 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101353002023-04-28 Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 Donovan, Johnny Deng, Zicheng Bian, Fenghua Shukla, Samriddhi Gomez-Arroyo, Jose Shi, Donglu Kalinichenko, Vladimir V. Kalin, Tanya V. Front Oncol Oncology Frontiers Media S.A. 2023-04-13 /pmc/articles/PMC10135300/ /pubmed/37124500 http://dx.doi.org/10.3389/fonc.2023.1163510 Text en Copyright © 2023 Donovan, Deng, Bian, Shukla, Gomez-Arroyo, Shi, Kalinichenko and Kalin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Donovan, Johnny Deng, Zicheng Bian, Fenghua Shukla, Samriddhi Gomez-Arroyo, Jose Shi, Donglu Kalinichenko, Vladimir V. Kalin, Tanya V. Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 |
| title | Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 |
| title_full | Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 |
| title_fullStr | Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 |
| title_full_unstemmed | Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 |
| title_short | Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1 |
| title_sort | corrigendum: improving anti-tumor efficacy of low-dose vincristine in rhabdomyosarcoma via the combination therapy with foxm1 inhibitor rcm1 |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135300/ https://www.ncbi.nlm.nih.gov/pubmed/37124500 http://dx.doi.org/10.3389/fonc.2023.1163510 |
| work_keys_str_mv | AT donovanjohnny corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT dengzicheng corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT bianfenghua corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT shuklasamriddhi corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT gomezarroyojose corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT shidonglu corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT kalinichenkovladimirv corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 AT kalintanyav corrigendumimprovingantitumorefficacyoflowdosevincristineinrhabdomyosarcomaviathecombinationtherapywithfoxm1inhibitorrcm1 |